entertainment -WSS

entertainment

author：focus 2025-10-01 15:30:17 - browse：74967

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： 7 of the most gruesome medical devices in history

WSS

Organ transplantation is at a crossroads. Major reform is needed

A double vaccine crisis is endangering millions of children

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

FDA official pushes for dedicated emerging pathogens team

Robert Kennedy Jr.'s presidential campaign attracts GOP

focus

entertainment

A looming test for neoantigen cancer vaccines

explore

Jerome Adams on the need for new antivirals for Covid

Robert Kennedy Jr.'s presidential campaign attracts GOP

Virginia high school admissions case could be legal follow

Russian special forces kill a gunman who broke into a private house near Moscow

ChatGPT in medicine: STAT answers readers' burning questions

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Anesthesiologist group: stop taking Ozempic before surgery

Johnson & Johnson sues to stop Medicare negotiation

The high cost of giving birth even with insurance

What we know about the American soldier detained in North Korea

focus

FDA seeking to stop procedures at two unregulated stem cell clinics

Lack of darker skin in textbooks, journals harms patients of color

Elizabeth Warren probes abortion access

Twill hunts for pharma partner to market its depression app

US soldier in North Korean custody after crossing DMZ line

Why you get paid to donate plasma but not blood

focus

focus

focus

hotspot